ANTARES PHARMA, INC. Insider Trading for June 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANTARES PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ANTARES PHARMA, INC. for June 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | Smith Karen L. | Director | Option Exercise | A | 2.92 | 46,729 | 136,449 | 46,729 | |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | Smith Karen L. | Director | Grant | A | 2.92 | 23,973 | 70,001 | 23,973 | 0 to 24 K |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | Greenleaf Peter | Director | Option Exercise | A | 2.92 | 46,729 | 136,449 | 46,729 | |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | Greenleaf Peter | Director | Grant | A | 2.92 | 23,973 | 70,001 | 23,973 | 0 to 24 K |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Option Exercise | A | 2.92 | 46,729 | 136,449 | 46,729 | |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Grant | A | 2.92 | 23,973 | 70,001 | 76,751 | 52.8 K to 76.8 K (+45.42 %) |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | ROCHE ROBERT P JR | Director | Option Exercise | A | 2.92 | 46,729 | 136,449 | 46,729 | |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | ROCHE ROBERT P JR | Director | Grant | A | 2.92 | 23,973 | 70,001 | 112,145 | 88.2 K to 112.1 K (+27.19 %) |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 2.92 | 46,729 | 136,449 | 46,729 | |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Grant | A | 2.92 | 23,973 | 70,001 | 326,749 | 302.8 K to 326.7 K (+7.92 %) |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 2.92 | 46,729 | 136,449 | 46,729 | |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Grant | A | 2.92 | 23,973 | 70,001 | 184,186 | 160.2 K to 184.2 K (+14.96 %) |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | A | 2.92 | 73,431 | 214,419 | 73,431 | |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Grant | A | 2.92 | 37,671 | 109,999 | 277,563 | 239.9 K to 277.6 K (+15.70 %) |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | Tursi James Patrick | EVP, Chief Medical ... | Option Exercise | A | 2.92 | 90,788 | 265,101 | 90,788 | |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | Tursi James Patrick | EVP, Chief Medical ... | Grant | A | 2.92 | 45,205 | 131,999 | 45,205 | 0 to 45.2 K |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Option Exercise | A | 2.92 | 170,227 | 497,063 | 170,227 | |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Grant | A | 2.92 | 84,760 | 247,499 | 386,261 | 301.5 K to 386.3 K (+28.11 %) |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Option Exercise | A | 2.92 | 181,575 | 530,199 | 181,575 | |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Grant | A | 2.92 | 90,411 | 264,000 | 485,610 | 395.2 K to 485.6 K (+22.88 %) |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | A | 2.92 | 567,423 | 1,656,875 | 567,423 | |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Grant | A | 2.92 | 282,534 | 824,999 | 1,849,336 | 1.6 M to 1.8 M (+18.03 %) |
| Jun 11 2019 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Payment of Exercise | F | 2.81 | 11,678 | 32,815 | 301,501 | 313.2 K to 301.5 K (-3.73 %) |
| Jun 11 2019 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Payment of Exercise | F | 2.81 | 11,678 | 32,815 | 301,501 | 313.2 K to 301.5 K (-3.73 %) |
| Jun 11 2019 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Payment of Exercise | F | 2.81 | 12,922 | 36,311 | 313,179 | 326.1 K to 313.2 K (-3.96 %) |
| Jun 11 2019 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Payment of Exercise | F | 2.81 | 12,922 | 36,311 | 313,179 | 326.1 K to 313.2 K (-3.96 %) |
| Jun 11 2019 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Payment of Exercise | F | 2.81 | 8,684 | 24,402 | 395,199 | 403.9 K to 395.2 K (-2.15 %) |
| Jun 11 2019 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Payment of Exercise | F | 2.81 | 9,609 | 27,001 | 403,883 | 413.5 K to 403.9 K (-2.32 %) |
| Jun 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.81 | 44,225 | 124,272 | 1,566,802 | 1.6 M to 1.6 M (-2.75 %) |
| Jun 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.81 | 48,936 | 137,510 | 1,611,027 | 1.7 M to 1.6 M (-2.95 %) |
| Jun 04 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.79 | 52,559 | 146,640 | 1,659,963 | 1.7 M to 1.7 M (-3.07 %) |
| Jun 04 2019 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Payment of Exercise | F | 2.79 | 15,421 | 43,025 | 326,101 | 341.5 K to 326.1 K (-4.52 %) |